ATE119781T1 - Antikoagulanszubereitung. - Google Patents

Antikoagulanszubereitung.

Info

Publication number
ATE119781T1
ATE119781T1 AT91912208T AT91912208T ATE119781T1 AT E119781 T1 ATE119781 T1 AT E119781T1 AT 91912208 T AT91912208 T AT 91912208T AT 91912208 T AT91912208 T AT 91912208T AT E119781 T1 ATE119781 T1 AT E119781T1
Authority
AT
Austria
Prior art keywords
epi
increase
anticoagulant preparation
anticoagulant
preparation
Prior art date
Application number
AT91912208T
Other languages
English (en)
Inventor
Ole Juul Nordfang
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE119781T1 publication Critical patent/ATE119781T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Materials For Medical Uses (AREA)
AT91912208T 1990-06-19 1991-05-30 Antikoagulanszubereitung. ATE119781T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK148890A DK148890D0 (da) 1990-06-19 1990-06-19 Farmaceutisk praeparat

Publications (1)

Publication Number Publication Date
ATE119781T1 true ATE119781T1 (de) 1995-04-15

Family

ID=8105367

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91912208T ATE119781T1 (de) 1990-06-19 1991-05-30 Antikoagulanszubereitung.

Country Status (11)

Country Link
EP (1) EP0535129B1 (de)
JP (1) JP3362038B2 (de)
AT (1) ATE119781T1 (de)
AU (1) AU645581B2 (de)
BG (1) BG61181B1 (de)
CA (1) CA2085101A1 (de)
DE (1) DE69108242T2 (de)
DK (2) DK148890D0 (de)
ES (1) ES2069894T3 (de)
HU (1) HU221323B1 (de)
WO (1) WO1991019514A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291427B1 (en) 1990-08-27 2001-09-18 G.D. Searle & Co. Anticoagulant combination of LACI and sulfated polysaccharides
US5849703A (en) * 1990-08-27 1998-12-15 G. D. Searle & Co. Pre-formed anticoagulant heparin/TFPI complexes
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
KR950701820A (ko) * 1992-06-11 1995-05-17 로저 에이. 윌리암스 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders)
ZA941414B (en) * 1993-03-02 1994-09-28 Novo Nordisk A G Non-glycosylated TFPI analogues
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
EA200400548A1 (ru) 2001-10-15 2005-06-30 Чирон Корпорейшн Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3170001D1 (en) * 1980-09-30 1985-05-23 Bayer Ag Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
IL79255A0 (en) * 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
US4900723A (en) * 1988-04-29 1990-02-13 E. R. Squibb & Sons, Inc. Method of preventing or reducing venous thrombosis using a thromboxane A2 receptor antagonist in conjunction with heparin and combination
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner

Also Published As

Publication number Publication date
CA2085101A1 (en) 1991-12-20
AU8060491A (en) 1992-01-07
WO1991019514A1 (en) 1991-12-26
HUT63578A (en) 1993-09-28
EP0535129A1 (de) 1993-04-07
AU645581B2 (en) 1994-01-20
HU221323B1 (en) 2002-09-28
DK148890D0 (da) 1990-06-19
BG97199A (bg) 1993-12-24
JP3362038B2 (ja) 2003-01-07
BG61181B1 (bg) 1997-02-28
DE69108242D1 (de) 1995-04-20
ES2069894T3 (es) 1995-05-16
DE69108242T2 (de) 1995-07-06
DK0535129T3 (da) 1995-08-07
HU9204036D0 (en) 1993-03-29
EP0535129B1 (de) 1995-03-15
JPH05507926A (ja) 1993-11-11

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
MX9603925A (es) Combinaciones de anticoagulantes y proteinas activas tromboliticamente, y usos de las mismas.
HU9300636D0 (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
ATE119781T1 (de) Antikoagulanszubereitung.
BR9708406A (pt) Tratamento por fotoferese de infecções crÈnicas por hcv.
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
EA200400548A1 (ru) Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi)
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
ATE311191T1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
FI913625A0 (fi) Behandling av nedsatt funktion av leukocyter med gm-csf.
ES2107414T3 (es) Utilizacion de interferon-beta humano para la estimulacion de la eritropoyesis.
DK0651654T3 (da) Anvendelse af lysozymdimer til fremstilling af et lægemiddel til styrkelse af de naturlige forsvarsmekanismer
DK225689D0 (da) Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi
ATE458495T1 (de) Therapeutische zubereitung für autoimmune erkrankungen
SE9003181D0 (sv) Use of heparin fraction
EP0340933A3 (de) Heparin enthaltende Formulierungen
DE69128465D1 (de) Heparinneutralisierung durch blutplättchenfaktor
Nowicka et al. Disseminated intravascular coagulation (DIC) during superacute haemolysis in a patient with ovarian dermatoid cyst treated with rifampicin
Zhao et al. Compositive treatment of acute deep vein thrombosis of lower extremity
Balas et al. Venous Thrombosis in Childhood
Huet et al. Subcutaneous enoxaparin as anticoagulant therapy in acute pulmonary embolism in man
UA7180C2 (uk) Препарат для лікування та профілактики атерогенних дисліпопротеїнемій та синдрому гіперкоагуляції

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee